Market Research Logo

Europe Veterinary Healthcare Market

Europe Veterinary Healthcare Market

Europe Veterinary Healthcare Market
The market was valued at USD 6.61 million in the year 2016 and is expected to grow at a healthy CAGR of 4.98% to USD 8.43 million by the year 2021. The European swine healthcare market is the second largest in the world, amounting to USD 428.81 million in the year 2016 and is expected to grow at a CAGR of 7.51% to reach USD 615.9 million by the year 2021. It runs just behind the US in the global fish healthcare market, which happens to be another promising segment in European veterinary healthcare market

Market Dynamics

The report details several driving factors and restraints for the veterinary healthcare market in Europe. Some of these are listed below.

Drivers

Increase in pet ownership
Improved nutrition
Intensifying consumer focus on food safety
Growing awareness about livestock diseases
Restraints

Increased competition for cultivated land and cost-effective production are the hurdles faced by the Europe veterinary healthcare market.

The report provides an exhaustive coverage of the market with multi-level segmentation by animal species (farm animals and companion animals), type of healthcare products (vaccines, parasiticides, Anti-invectives, medicinal feed additives, and other pharmaceuticals) and geography. Regional coverage includes a study of the animal healthcare markets in France, Italy Germany, Spain, and Sweden.

Some of the key players in the market are:

Bayer Healthcare
Boehringer Ingelheim
Ceva Animal Health, Inc.
Elanco
Merck
Merial (Animal Health Division of Sanofi)
Virbac
What the Report Offers

Market definition for Europe’s veterinary healthcare market along with identification of key drivers and restraints for the market.
Market analysis for Europe’s veterinary healthcare market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect Europe’s veterinary healthcare market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.


1. INTRODUCTION
1.1 Market Definition
1.2 Market Recent Trends
2 Market Analysis
2.1 Market Animal Health Products
2.2 Animal medicines vs. human Medicines
3. Market Dynamics
3.1 Market Drivers
3.1.1 Increase in pet ownership
3.1.2 Improved Nutrition
3.1.3 Intensifying consumer focus on food safety
3.1.4 Greater Livestock production
3.1.5 Increasing Zoonotic and Foodborne Diseases
3.2 Market Constraints
3.2 1 Scarcity of arable land and water
3.2.2 Increased competition for cultivated land
3.2.3 Cost-effective production
3.3 Porter's Five Force Analysis
3.3.1 Threat of New Entrant
3.3.2 Internal Rivalry
3.3.3 Buyer bargaining power
3.3.4 Supplier bargaining power
3.3.5 Threat of substitutes
4. Europe Veterinary healthcare Market Segmentation- Animal Types, based on products
4.1 Companion Animal health
4.1.1 Vaccines
4.1.2 Parasiticides
4.1.3 Anti-Infectives
4.1.4 Medicinal Feed Additives
4.1.5 Other Pharmaceuticals
4.2 Farm Animals
4.2.1 Vaccines
4.2.2 Parasiticides
4.2.3 Anti-Infectives
4.2.4 Medicinal Feed additives
4.2.5 Other Pharmaceuticals
5. Europe Veterinary Diagnostics Market
5.1 Enzyme Linked Immuno Sorbent Assay (ELISA)
5.2 Rapid Immuno Migration (RIM)
5.3 Agar gel Immuno Diffusion (AGID)
6. Europe Veterinary Genetics Market
6.1 HD 50K for Angus
6.2 CLARIFIDE® for Dairy
6.3 Sheep 50K
6.4 CLARIFIDE® for Nelore
7. Europe Veterinary Healthcare Market Segmentation- By Animal Species
7.1 Farm animal
7.1.1 Cattle
7.1.2 Swine
7.1.3 Poultry
7.1.4 Fish
7.1.5 Sheep
7.2 Companion Animals
7.2.1 Dogs
7.2.2 Cats
7.2.3 Horses
8. Europe Veterinary healthcare market- Country-level Analysis
8.1 France
8.2 Germany
8.3 Italy
8.4 Spain
8.5 Sweden
9. Competitive landscape
9.1 Major players in the market
9.2 Mergers and acquisitions
9.3 New product launches
9.4 Agreement, Collaborations, and Partnerships
10. Company profiles
10.1 Zoetis animal healthcare
10.1.1 Financial Overview
10.1.2 Business overview
10.1.3 Business strategies
10.2 Merck
10.2.1 Financial Overview
10.2.2 Business overview
10.2.3 Business strategies
10.3 Merial (Animal Health Division of Sanofi)
10.3.1 Financial Overview
10.3.2 Business overview
10.3.3 Business strategies
10.4 Elanco
10.4.1 Financial Overview
10.4.2 Business overview
10.4.3 Business strategies
10.5 Bayer healthcare
10.5.1 Financial Overview
10.5.2 Business overview
10.5.3 Business strategies
10.6 Ceva Animal Health, Inc.
10.6.1 Financial Overview
10.6.2 Business overview
10.6.3 Business strategies
10.7 Virbac
10.7.1 Financial Overview
10.7.2 Business overview
10.7.3 Business strategies
10.8 Boehringer Ingelheim
10.8.1 Financial Overview
10.8.1 Business overview
10.8.1 Business strategies
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Bibliography
11.4. Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report